Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Abstracts
Neurology
2
Mins
7 Aug 2018
Efficacy of Training in a Virtual Environment for Patients with Balance Disturbances
For many years, force platforms and centre of pressure biofeedback were used as tools for static balance training. However, thanks to motion tracking…
Neurology
1
Mins
7 Aug 2018
Trazodone in Dravet Syndrome
Dravet syndrome (DS) is an epileptic encephalopathy most commonly associated with SCN1A mutations and is typically refractory to antiepileptic drugs (AED).
Hematology
2
Mins
2 Aug 2018
Polymorphisms in Multidrug Resistance Transporter Genes Affect the Duration of Molecular Response to Nilotinib in Chronic Myeloid Leukaemia Patients
Despite the high efficacy and improved clinical response of nilotinib in chronic myeloid leukaemia (CML), there is still a significant proportion of…
Hematology
2
Mins
2 Aug 2018
Inherited Platelet Disorders Caused by Thrombopoietin Mutation
Thrombopoietin (THPO) and the interaction with its receptor c-Mpl have a nonredundant role in platelet biogenesis and maintenance of the haematopoietic…
Hematology
1
Mins
2 Aug 2018
Bacterial Contamination of Platelet Transfusion Units Affects Platelet Haemostatic Function and Immunological Activity
Transfusion-associated bacterial infection is a major risk of platelet transfusion and can be fatal. The storage requirements of platelet concentrates…
Hematology
2
Mins
2 Aug 2018
Lenalidomide: The Gift That Keeps on Giving
First-line therapy for indolent non-Hodgkin’s lymphoma usually consists of a combination of rituximab-based chemoimmunotherapy. Historically, first-line…
Hematology
1
Mins
2 Aug 2018
A Targeted Next-Generation Sequencing-Based Diagnosis for Hereditary Anaemias
Anaemia affects 1.6 billion people worldwide, with roughly 10% of these individuals affected by rare anaemias, of which 80% are hereditary. Hereditary…
Hematology
1
Mins
2 Aug 2018
Genes and Pathways Dysregulated by Nilotinib Treatment in Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukaemia
Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder with heterogeneous biological and clinical features. Specifically, it presents a…
Loading posts...
« Previous
1
…
71
72
73
74
75
…
108
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View